Jan. 15, 2025 — Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. ... New Innovative Local Treatment ...
Completed enrollment in Phase 2 BESTOW trial assessing tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Presented updat ...
IRVINE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon”) (Nasdaq: ELDN) today announced a summary of 2024 accomplishments and provided guidance for anticipated 2025 ...
Increased delay to lung transplantation for women candidates: gender-based disparity matters in the lung transplant ...
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you. Daily news – Get the most important news from ...
Express US takes a look at the products which have been recalled by the Food and Drug Administration since the start of January.
It may even be best to avoid it altogether. Pomegranate juice may also affect other drugs, such as tacrolimus, an anti-rejection drug used in organ transplants. Similarly, a number of case reports ...
Biocon said that it's wholly owned subsidiary, Biocon Pharma, has received approval for Tacrolimus capsule in 0.5mg, 1mg and 5mg strengths, from the National Medical Products Administration (NMPA), ...
Bangalore: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval for Tacrolimus capsule in 0.5mg, 1mg and 5mg strengths, from the National ...
Biotechnology company Biocon Ltd stated on Thursday (January 2) that its wholly owned subsidiary, Biocon Pharma Ltd, has acquired permission from the National Medical Products Administration (NMPA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback